Tenaya Therapeutics Publishes Preclinical Data in Circulation Highlighting the Clinical ...
SOUTH SAN FRANCISCO, Calif., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies
Source: eagletribune.com